663 results on '"Soares, Andreimar M."'
Search Results
152. Comparison between apo and complexed structures of bothropstoxin-I reveals the role of Lys122 and Ca2+-binding loop region for the catalytically inactive Lys49-PLA2s
153. Crystallization and preliminary X-ray crystallographic studies of a Lys49-phospholipase A2homologue fromBothrops pirajaivenom complexed with rosmarinic acid
154. Corrigendum to “An a-type phospholipase A2 inhibitor from Bothrops jararacussu snake plasma: Structural and functional characterization” [Biochimie 90 (2008) 1506–1514]
155. Crystal structure of a phospholipase A2 homolog complexed with p-bromophenacyl bromide reveals important structural changes associated with the inhibition of myotoxic activity
156. Acute toxicity of Schizolobium parahyba aqueous extract in mice
157. Antitumor effects of snake venom chemically modified Lys49 phospholipase A2-like BthTX-I and a synthetic peptide derived from its C-terminal region
158. Expression of Human Recombinant Antibody Fragments Capable of Partially Inhibiting the Phospholypase Activity ofCrotalus durissus terrificusVenom
159. Crotalus durissus collilineatus venom gland transcriptome: Analysis of gene expression profile
160. BjussuSP-I: A new thrombin-like enzyme isolated from Bothrops jararacussu snake venom
161. Crystallization and Preliminary X-Ray Crystallographic Studies of a Myotoxic Lys49-phospholipase A2 from Bothrops jararacussu Venom Complexed with α-Tocopherol Inhibitor
162. An α-type phospholipase A2 inhibitor from Bothrops jararacussu snake plasma: Structural and functional characterization
163. RETRACTED: Antiviral and antiparasite properties of an l-amino acid oxidase from the Snake Bothrops jararaca: Cloning and identification of a complete cDNA sequence
164. Neutralization of Pharmacological and Toxic Activities of Bothrops Snake Venoms by Schizolobium parahyba (Fabaceae) Aqueous Extract and Its Fractions
165. Anti-snake venom properties ofSchizolobium parahyba(Caesalpinoideae) aqueous leaves extract
166. Crystal structure of a myotoxic Asp49-phospholipase A2 with low catalytic activity: Insights into Ca2+-independent catalytic mechanism
167. Molecular characterization of BjussuSP-I, a new thrombin-like enzyme with procoagulant and kallikrein-like activity isolated from Bothrops jararacussu snake venom
168. Insights into the role of oligomeric state on the biological activities of crotoxin: Crystal structure of a tetrameric phospholipase A2formed by two isoforms of crotoxin B fromCrotalus durissus terrificusvenom
169. Neutralization of snake venom phospholipase A2 toxins by aqueous extract of Casearia sylvestris (Flacourtiaceae) in mouse neuromuscular preparation
170. Cytotoxic l-amino acid oxidase from Bothrops moojeni: Biochemical and functional characterization
171. Molecular approaches for structural characterization of Bothropsl-amino acid oxidases with antiprotozoal activity: cDNA cloning, comparative sequence analysis, and molecular modeling
172. Structural Basis for the Inhibition of a Phospholipase A2-Like Toxin by Caffeic and Aristolochic Acids.
173. Photobiostimulation reduces edema formation induced in mice by Lys-49 phospholipases A2 isolated from Bothrops moojeni venom.
174. Bothrops moojeni myotoxin-II, a Lys49-phospholipase A2 homologue: An example of function versatility of snake venom proteins
175. Structure of BthA-I complexed withp-bromophenacyl bromide: possible correlations with lack of pharmacological activity
176. Medicinal Plants with Inhibitory Properties Against Snake Venoms
177. Anticoagulant and antifibrinogenolytic properties of the aqueous extract from Bauhinia forficata against snake venoms
178. Structural insights for fatty acid binding in a Lys49-phospholipase A2: crystal structure of myotoxin II from Bothrops moojeni complexed with stearic acid
179. Biological and enzymatic activities of Micrurus sp. (Coral) snake venoms
180. Purification and Characterization of Jararassin-I, A Thrombin-like Enzyme from <italic>Bothrops jararaca</italic> Snake Venom
181. Neo-clerodane diterpenoid, a new metalloprotease snake venom inhibitor from Baccharis trimera (Asteraceae): anti-proteolytic and anti-hemorrhagic properties
182. Crystal structure of an acidic platelet aggregation inhibitor and hypotensive phospholipase A2 in the monomeric and dimeric states: insights into its oligomeric state
183. Signal transduction pathways involved in the platelet aggregation induced by a D-49 phospholipase A2 isolated from Bothrops jararacussu snake venom
184. Cloning and expression of an acidic platelet aggregation inhibitor phospholipase A2 cDNA from Bothrops jararacussu venom gland
185. Platelet Aggregation and Antibacterial Effects of an L‐Amino Acid Oxidase Purified from Bothrops alternatus Snake Venom.
186. Crystallization and preliminary X-ray diffraction analysis of an acidic phospholipase A2 complexed with p-bromophenacyl bromide and α-tocopherol inhibitors at 1.9- and 1.45-Å resolution
187. Analysis of Bothrops jararacussu venomous gland transcriptome focusing on structural and functional aspects11All sequence data reported in this paper will appear in the GenBank database under the following accession numbers: BOJU-I (AY 185200), BOJU-II (AY 185206), BOJU-III (AY 145836), BOJUMET-I (AY 55005), BOJUMET-II (AY 25584), BOJUMET-III (AY 258153), C-type lectin (AY 251283), serine-proteases (AY 251282).: I—gene expression profile of highly expressed phospholipases A2
188. Alkylation of myotoxic phospholipases A2 in Bothrops moojeni venom: a promising approach to an enhanced antivenom production
189. Crystal structures of BnSP-7 and BnSP-6, two Lys49-phospholipases A2: quaternary structure and inhibition mechanism insights
190. Inhibition of enzymatic and pharmacological activities of some snake venoms and toxins by Mandevilla velutina (Apocynaceae) aqueous extract
191. Structural and functional analysis of BmjMIP, a phospholipase A2 myotoxin inhibitor protein from Bothrops moojeni snake plasma
192. Structural and functional characterization of an acidic platelet aggregation inhibitor and hypotensive phospholipase A2 from Bothrops jararacussu snake venom
193. cDNA sequence and molecular modeling of a nerve growth factor from Bothrops jararacussu venomous gland
194. Mn2+ ions reduce the enzymatic and pharmacological activities of bothropstoxin-I, a myotoxic Lys49 phospholipase A2 homologue from Bothrops jararacussu snake venom
195. Inhibitory properties of the anti-bothropic complex from Didelphis albiventris serum on toxic and pharmacological actions of metalloproteases and myotoxins from bothrops asper venom 1 1Abbreviations: SVMPs, snake venom metalloproteases; ABC, anti-bothropic complex from Didelphis albiventris serum; DA43, 43-kDa subunit of anti-bothropic complex from D. albiventris serum; DA45, 45-kDa subunit of anti-bothropic complex from D. albiventris serum; MHD, dose able to induce a hemorrhagic lesion of 10 mm diameter; BaP1, basic hemorrhagic metalloprotease from Bothrops asper venom; BaH4, acidic hemorrhagic metalloprotease from B. asper venom; Basp-I, myotoxin I from B. asper venom; Basp-II, myotoxin II from B. asper venom; and Basp-III, myotoxin III from B. asper venom.
196. Effects of chemical modifications of crotoxin B, the phospholipase A2 subunit of crotoxin from Crotalus durissus terrificus snake venom, on its enzymatic and pharmacological activities
197. Pathological alterations induced by neuwiedase, a metalloproteinase isolated from Bothrops neuwiedi snake venom
198. Immunochemical properties of the N-terminal helix of myotoxin II, a lysine-49 phospholipase A2 from Bothrops asper snake venom
199. Dissociation of Enzymatic and Pharmacological Properties of Piratoxins-I and -III, Two Myotoxic Phospholipases A2 from Bothrops pirajai Snake Venom
200. Crystallization and preliminary x-ray diffraction studies of bnsp-6, a myotoxic phospholipase a2 from bothrops neuwiedi venom
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.